Received Jul 26, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
stroke; This serious case was reported by a consumer via interactive digital media and described the occurrence of stroke in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced stroke (Verbatim: stroke) (serious criteria GSK medically significant). The outcome of the stroke was not reported. It was unknown if the reporter considered the stroke to be related to Shingrix. The company considered the stroke to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 21-JUL-2026 This case was reported by a patient's husband via interactive digital media. The reporter said not to administer the Shingrix vaccine. The batch number was not provided and unable to contact the reporter.; Sender's Comments: A case of Cerebrovascular accident, on an unknown time after vaccination with unknown dose of Shingrix, in a female patient. Based on the available information a possible causality that the event was caused by GSK vaccine product cannot be ascertained. Consent for further follow up has not been received.